Can someone confirm that the index to enter in the sample sheet for PhiX V3 demultiplexing is TTAGGC (IDX3, as read)? Got 30G "undetermined indices" on control lane.
-
-
Index #3 is indeed TTAGGC
How many other indexed reads did you have in the control lane? Or was that the only one? -
I know IDX3 is TTAGGC, but is that the index used for PhiX control, version 3?Originally posted by westerman View Post
I realize now it failed because it was the only index and we should have left the index field empty. But if we do want to use it for spike in, we need to know its index.Comment
-
Wow, I was just looking for this information myself this morning. I haven't found an authoritative source yet though. I highly doubt that Illumina would use an index sequence from their library prep set though; that would preclude being able to use that index for one of your samples if you wanted to spike in some phiX.Originally posted by HMorrison View Post
Simply reading the %Base graph for our control lane though the index appears to be GTATGC. What is odd is that this sequence appears downstream of the index in all of the TruSeq adapters.Comment
-
They did use IDX3 before this; we verified that when we were using earlier kits and Casava 1.7 where we could actually look at the index reads. Now with 1.8, I can't do that. I may have to go back and run with 1.7.Originally posted by kmcarr View PostComment
-
I talked to techsupport the other week, and PhiX v3 does not contain an Index. Only if multiplexing PhiX is indexed with index #3. This version of PhiX is no longer being made or sold.Comment
-
What about:Originally posted by hoisinjl View Post
PE-400-2002 | Multiplexing Sequencing Primer and PhiX Control Kit v2.0 (10 flow cells)
Wouldn't that have bar coded PhiX in it?
--
PhillipComment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment